Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX3CQ2
|
||||
Drug Name |
N-(3-(benzo[d]thiazol-2-yl)phenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
|
||||
Synonyms |
CHEMBL490555
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C19H13N5S
|
||||
Canonical SMILES |
N(c1cccc(c1)c2nc3ccccc3s2)c4ncnc5[nH]ccc45
|
||||
InChI |
InChI=1S/C19H13N5S/c1-2-7-16-15(6-1)24-19(25-16)12-4-3-5-13(10-12)23-18-14-8-9-20-17(14)21-11-22-18/h1-11H,(H2,20,21,22,23)
|
||||
InChIKey |
BMGGDZTXJBWQCN-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Aurora kinase B | Target Info | [1587926] | ||
Angiopoietin 1 receptor | Target Info | [1587926] | |||
NetPath Pathway | Wnt Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
WikiPathways | Mitotic Metaphase and Anaphase | ||||
Mitotic Prometaphase | |||||
Regulation of Microtubule Cytoskeleton | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
APC/C-mediated degradation of cell cycle proteinsWP363:Wnt Signaling Pathway Netpath | |||||
Cell surface interactions at the vascular wall | |||||
Angiogenesis | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.